Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase IV, Single-arm, Open-label Study of Sorafenib (Nexavar®) in Advanced Hepatocellular Carcinoma (HCC)

NCT01098760 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01098760
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01098760 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase IV, Single-arm, Open-label Study of Sorafenib (Nexavar®) in Advanced Hepatocellular Carcinoma (HCC)
Lead sponsor
Bayer
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2010
Completion date
October 31, 2013
Enrollment
151 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma